Noncontraceptive effects of hormonal contraceptives: Bone mass, sexually transmitted disease and pelvic inflammatory disease, cardiovascular disease, menstrual function, and future fertility
- 1 May 1994
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 170 (5) , 1569-1575
- https://doi.org/10.1016/s0002-9378(12)91817-7
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys.Journal of Clinical Investigation, 1991
- Bone density in women receiving depot medroxyprogesterone acetate for contraception.BMJ, 1991
- Cofactors in Male-Female Sexual Transmission of Human Immunodeficiency Virus Type 1The Journal of Infectious Diseases, 1991
- Efficacy and Clinical Profile of a New Oral Contraceptive Containing Norgestimate: U.S. Clinical TrialsActa Obstetricia et Gynecologica Scandinavica, 1990
- Risk factors for male to female transmission of HIV. European Study Group.BMJ, 1989
- A Prospective Study of Past Use of Oral Contraceptive Agents and Risk of Cardiovascular DiseasesNew England Journal of Medicine, 1988
- Chlamydial Salpingitis in Female Guinea Pigs Receiving Oral ContraceptivesSexually Transmitted Diseases, 1988
- Involutional OsteoporosisNew England Journal of Medicine, 1986
- Absence of Progesterone Effects on Chlamydial Genital Infection in Female Guinea PigsSexually Transmitted Diseases, 1985
- Fertility after stopping use of intrauterine contraceptive device.BMJ, 1983